Literature DB >> 9239539

Mitochondrial DNA mutations and pathogenesis.

E A Schon1, E Bonilla, S DiMauro.   

Abstract

Approximately there years ago, this journal published a review on the clinical and molecular analysis of mitochondrial encephalomyopathies, with emphasis on defects in mitochondrial DNA (mtDNA). At the time, approximately 30 point mutations associated with a variety of maternally-inherited (or rarely, sporadic) disorders had been described. Since that time, almost twenty new pathogenic mtDNA point mutations have been described, and the pace of discovery of such mutations shows no signs of abating. This accumulating body of data has begun to reveal some patterns that may be relevant to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9239539     DOI: 10.1023/a:1022685929755

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  177 in total

1.  Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  J F Hess; M A Parisi; J L Bennett; D A Clayton
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

2.  A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy.

Authors:  K Fu; R Hartlen; T Johns; A Genge; G Karpati; E A Shoubridge
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

3.  Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis.

Authors:  H Nakase; C T Moraes; R Rizzuto; A Lombes; S DiMauro; E A Schon
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

4.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

5.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

6.  Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia.

Authors:  A Rötig; J L Bessis; N Romero; V Cormier; J M Saudubray; P Narcy; G Lenoir; P Rustin; A Munnich
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

7.  Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease.

Authors:  N Howell; I Kubacka; R Smith; F Frerman; J K Parks; W D Parker
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

8.  Myoclonic epilepsy with ragged-red fibers (MERRF): an immunohistochemical study of the brain.

Authors:  M Sparaco; E A Schon; S DiMauro; E Bonilla
Journal:  Brain Pathol       Date:  1995-04       Impact factor: 6.508

9.  A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  Y Goto; K Tsugane; Y Tanabe; I Nonaka; S Horai
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

View more
  79 in total

1.  Effects of disrupting the 21 kDa subunit of complex I from Neurospora crassa.

Authors:  F Ferreirinha; M Duarte; A M Melo; A Videira
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep.

Authors:  M J Evans; C Gurer; J D Loike; I Wilmut; A E Schnieke; E A Schon
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

3.  Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases.

Authors:  R Rossignol; T Letellier; M Malgat; C Rocher; J P Mazat
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 4.  Mitochondrial DNA analysis: polymorphisms and pathogenicity.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

5.  Relaxed replication of mtDNA: A model with implications for the expression of disease.

Authors:  P F Chinnery; D C Samuels
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 6.  Mitochondria as all-round players of the calcium game.

Authors:  R Rizzuto; P Bernardi; T Pozzan
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

Review 7.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 8.  Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?

Authors:  C Florentz; M Sissler
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

9.  Mitochondrial myopathy, cardiomyopathy and psychiatric illness in a Spanish family harbouring the mtDNA 3303C > T mutation.

Authors:  Y Campos; A García; J Eiris; M Fuster; J C Rubio; M A Martín; P del Hoyo; E Pintos; M Castro-Gago; J Arenas
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

10.  Human mtDNA haplogroups associated with high or reduced spermatozoa motility.

Authors:  E Ruiz-Pesini; A C Lapeña; C Díez-Sánchez; A Pérez-Martos; J Montoya; E Alvarez; M Díaz; A Urriés; L Montoro; M J López-Pérez; J A Enríquez
Journal:  Am J Hum Genet       Date:  2000-08-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.